The global Veterinary Oncology Market Growth Accelerated by Innovations in Veterinary Cancer Diagnosis and Treatment Methods
Veterinary oncology deals with the diagnosis, prevention, and treatment of cancer in pets. Veterinary oncology has gained significant importance over the years. Early detection and accurate diagnosis are crucial for the successful treatment of cancer in pets. Innovations in diagnostic and imaging techniques allow veterinarians to detect cancers in their early stages. Advanced treatment options such as chemotherapy, radiation therapy, immunotherapy, and targeted therapy have improved the survival rates and quality of life of pets suffering from cancer.
The
global Veterinary Oncology Market is estimated to be valued at US$ 657.42 Mn in
2023 and is expected to exhibit a CAGR
of 14% over the forecast period 2023 to 2030, as highlighted in a new
report published by Coherent Market Insights.
Market key trends:
Innovations in veterinary cancer diagnostic techniques have been a key
trend fueling market growth. Non-invasive imaging modalities such as CT, MRI,
and PET scans have improved early detection capabilities. These advanced
imaging techniques help veterinarians detect tumors that may not be identified
on regular X-rays. They provide high-resolution anatomical images that help
determine the size, location, and spread of tumors. Innovations in imaging
techniques have streamlined the diagnostic process and enabled veterinarians to
diagnose cancers at their earliest stages. This has significantly improved
treatment outcomes and quality of life of pets suffering from cancer.
Segment Analysis
The global
veterinary oncology market size is dominated by the companion animal
segment. Within companion animals, canine oncology accounts for a major share
due to factors such as rising pet adoption and expenditure on pets, increasing
awareness about cancer diagnosis and treatment in dogs, and their comparable
genotypes and molecular signaling pathways to humans. The canine segment is
expected to witness high growth over the forecast period as well.
Key Takeaways
The global veterinary oncology market is expected to witness high growth
over the forecast period of 2023 to 2030. The global Veterinary Oncology Market
is estimated to be valued at US$ 657.42 Mn in 2023 and is expected to exhibit a
CAGR of 14% over the forecast period 2023 to 2030.
Regional
analysis shows that North America currently dominates the market due to growing
veterinary healthcare expenditure and increasing adoption of advanced
technologies for cancer diagnosis and treatment in pets. Europe holds the
second largest share owing to rising animal health awareness and increasing
number of veterinary practitioners. Asia Pacific exhibits the fastest growth
rate led by improving pet care standards, increasing pet healthcare
expenditure, and growing adoption of advanced therapies.
Key players operating in the veterinary oncology market are Thermo Fisher
Scientific Inc., CRISPR Therapeutics AG, Intellia Therapeutics. Thermo Fisher
Scientific Inc. offers a wide range of solutions for cancer research including
flow cytometry, microscopy, cell culture, IHC staining, and genomic analysis.
CRISPR Therapeutics AG is a biopharmaceutical company focused on developing
transformative gene-based medicines for serious diseases using its leading
gene-editing platform CRISPR/Cas9. Intellia Therapeutics leverages its
proprietary in vivo CRISPR/Cas9 gene editing technology to develop curative
single-administration therapies that provide long-lasting effects for patients
suffering from genetic diseases.
Get
more insights on this topic: https://www.newsstatix.com/veterinary-oncology-market-share-and-opportunity-analysis/
Explore
more information, Please visit: https://allmeaninginhindi.com/unveiling-the-stealthy-threat-of-catheter-related-blood-stream-infection/
Comments
Post a Comment